649735-46-6
649735-46-6
Chemical Structure
Brivanib
Synonym(s): BMS-540215
- CAS No.: 649735-46-6
- Formula:C19H19FN4O3
- Molecular Weight:370.38
IUPAC Name: (R)-1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-ol
InChIKey: WCWUXEGQKLTGDX-LLVKDONJSA-N
SMILES: FC1=C(OC2=NC=NN3C2=C(C(OC[C@H](O)C)=C3)C)C=CC4=C1C=C(C)N4
Biological Activity: Brivanib (BMS-540215) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM, and has moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Brivanib | 99.45% | Brivanib (BMS-540215) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM, and has moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Brivanib (Standard) | ≥98% | Brivanib (Standard) is the analytical standard of Brivanib. This product is intended for research and analytical applications. Brivanib (BMS-540215) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM, and has moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
